{"id":"https://openalex.org/W1946967684","doi":null,"title":"Potentiation of topoisomerase inhibitor-induced DNA strand breakage and cytotoxicity by tumor necrosis factor: enhancement of topoisomerase activity as a mechanism of potentiation.","display_name":"Potentiation of topoisomerase inhibitor-induced DNA strand breakage and cytotoxicity by tumor necrosis factor: enhancement of topoisomerase activity as a mechanism of potentiation.","publication_year":1990,"publication_date":"1990-05-01","ids":{"openalex":"https://openalex.org/W1946967684","mag":"1946967684","pmid":"https://pubmed.ncbi.nlm.nih.gov/2158396"},"language":"en","primary_location":{"id":"pmid:2158396","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2158396","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5077000893","display_name":"Teruhiro Utsugi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T Utsugi","raw_affiliation_strings":["Department of Immunology, Smith Kline & French Laboratories, King of Prussia, Pennsylvania 19406"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Immunology, Smith Kline & French Laboratories, King of Prussia, Pennsylvania 19406","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041975716","display_name":"Michael R. Mattern","orcid":"https://orcid.org/0000-0002-8595-000X","observed_orcids":["https://orcid.org/0000-0002-8595-000X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M R Mattern","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019123596","display_name":"Christopher K. Mirabelli","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C K Mirabelli","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5074473587","display_name":"Nabil Hanna","orcid":"https://orcid.org/0000-0002-3288-5486","observed_orcids":["https://orcid.org/0000-0002-3288-5486"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N Hanna","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.7509,"has_fulltext":false,"cited_by_count":60,"citation_normalized_percentile":{"value":0.9120278,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":93},"biblio":{"volume":"50","issue":"9","first_page":"2636","last_page":"40"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.9990000128746033},{"id":"https://openalex.org/keywords/topoisomerase-inhibitors","display_name":"topoisomerase inhibitors","score":0.968999981880188},{"id":"https://openalex.org/keywords/camptothecin","display_name":"camptothecin","score":0.843999981880188},{"id":"https://openalex.org/keywords/topoisomerase-i","display_name":"topoisomerase I","score":0.8190000057220459},{"id":"https://openalex.org/keywords/topoisomerase-ii","display_name":"topoisomerase II","score":0.9990000128746033},{"id":"https://openalex.org/keywords/teniposide","display_name":"teniposide","score":0.8069999814033508},{"id":"https://openalex.org/keywords/amsacrine","display_name":"amsacrine","score":0.9900000095367432},{"id":"https://openalex.org/keywords/etoposide","display_name":"etoposide","score":0.8970000147819519},{"id":"https://openalex.org/keywords/bleomycin","display_name":"bleomycin","score":0.878000020980835},{"id":"https://openalex.org/keywords/dna-strand-breaks","display_name":"DNA strand breaks","score":0.8130000233650208},{"id":"https://openalex.org/keywords/synergistic-cytotoxicity","display_name":"synergistic cytotoxicity","score":0.8669999837875366},{"id":"https://openalex.org/keywords/l929-fibrosarcoma-cells","display_name":"L929 fibrosarcoma cells","score":0.8970000147819519},{"id":"https://openalex.org/keywords/topoisomerase-activity","display_name":"topoisomerase activity","score":0.7379999756813049},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.39500001072883606}],"concepts":[{"id":"https://openalex.org/C2780500152","wikidata":"https://www.wikidata.org/wiki/Q2784004","display_name":"Amsacrine","level":4,"score":0.9369986653327942},{"id":"https://openalex.org/C147897179","wikidata":"https://www.wikidata.org/wiki/Q407828","display_name":"Topoisomerase","level":3,"score":0.9092928767204285},{"id":"https://openalex.org/C2778707968","wikidata":"https://www.wikidata.org/wiki/Q417555","display_name":"Teniposide","level":4,"score":0.8943065404891968},{"id":"https://openalex.org/C2779682216","wikidata":"https://www.wikidata.org/wiki/Q419964","display_name":"Camptothecin","level":2,"score":0.8920127153396606},{"id":"https://openalex.org/C2778119113","wikidata":"https://www.wikidata.org/wiki/Q418817","display_name":"Etoposide","level":3,"score":0.8687926530838013},{"id":"https://openalex.org/C2778616834","wikidata":"https://www.wikidata.org/wiki/Q281044","display_name":"Topoisomerase inhibitor","level":4,"score":0.63669353723526},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.5688639879226685},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.4574848711490631},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.4444529116153717},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.43010950088500977},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.41266930103302},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.39263516664505005},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.37622466683387756},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.341861367225647},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.20146599411964417},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.17051517963409424},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.10510313510894775},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000677","descriptor_name":"Amsacrine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004249","descriptor_name":"DNA Damage","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D004250","descriptor_name":"DNA Topoisomerases, Type II","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D004264","descriptor_name":"DNA Topoisomerases, Type I","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059004","descriptor_name":"Topoisomerase I Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D059005","descriptor_name":"Topoisomerase II Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":3,"locations":[{"id":"pmid:2158396","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2158396","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.321.2507","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.321.2507","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://cancerres.aacrjournals.org/content/50/9/2636.full.pdf","raw_type":"text"},{"id":"mag:1946967684","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2158396","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9074000120162964}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":22,"referenced_works":["https://openalex.org/W96728624","https://openalex.org/W1514525963","https://openalex.org/W1529230134","https://openalex.org/W1536538430","https://openalex.org/W1551187478","https://openalex.org/W1566761847","https://openalex.org/W1598282819","https://openalex.org/W1644277640","https://openalex.org/W1776295853","https://openalex.org/W1954622523","https://openalex.org/W1973057627","https://openalex.org/W1982323444","https://openalex.org/W1987000956","https://openalex.org/W2007451263","https://openalex.org/W2016254453","https://openalex.org/W2043047471","https://openalex.org/W2052450573","https://openalex.org/W2081482521","https://openalex.org/W2093993014","https://openalex.org/W2105054347","https://openalex.org/W2128635872","https://openalex.org/W2403137753"],"related_works":["https://openalex.org/W7095814395","https://openalex.org/W1620348927","https://openalex.org/W1994031750","https://openalex.org/W7073528893","https://openalex.org/W2087450993","https://openalex.org/W1524737496","https://openalex.org/W3012483614","https://openalex.org/W7099156341","https://openalex.org/W1965553853","https://openalex.org/W4252912054"],"abstract_inverted_index":{"A":[0],"combination":[1,38],"of":[2,39,47,52,64,69,125,131,145,167,179,192,201,221,234,237,239,263,265],"tumor":[3,53],"necrosis":[4],"factor":[5],"(TNF)":[6],"and":[7,19,41,114,173,183,195,232,241],"the":[8,14,26,45,50,62,67,89,132,143,162,199,222,230,235,260],"topoisomerase":[9,15,57,78,90,226,269],"I":[10,58,182],"inhibitor,":[11],"camptothecin,":[12,115],"or":[13,59,121,139,147,207],"II":[16,60],"inhibitors,":[17,61],"teniposide":[18],"amsacrine,":[20,116],"produced":[21,170],"dose-dependent":[22],"synergistic":[23,245],"cytotoxicity":[24],"against":[25],"murine":[27],"L929":[28,82,168,266],"fibrosarcoma":[29],"cells.":[30],"Similar":[31],"synergy":[32],"was":[33,80],"not":[34,101],"observed":[35,157],"with":[36,88,112,134,161,252],"a":[37,171,253],"TNF":[40,48,65,98,113,135,165,193,240],"bleomycin.":[42],"To":[43],"define":[44],"role":[46,254],"in":[49,75,150,158,176,212,224,259],"augmentation":[51],"cell":[54,216],"killing":[55,264],"by":[56,77,196,268],"effect":[63],"on":[66],"production":[68],"enzyme-linked":[70],"DNA":[71,103,257],"strand":[72,94,104,126,153],"breaks":[73,127,154],"induced":[74],"cells":[76,83,108,133,159,169,267],"inhibitors":[79,91,242],"investigated.":[81],"incubated":[84,110,160],"for":[85,136,243,255],"1":[86],"h":[87,141],"contained":[92],"protein-linked":[93],"breaks.":[95],"In":[96],"contrast,":[97],"alone":[99],"did":[100],"induce":[102],"breakage.":[105],"However,":[106],"when":[107],"were":[109,128,187,204],"simultaneously":[111],"Adriamycin,":[117],"actinomycin":[118],"D,":[119],"teniposide,":[120],"etoposide,":[122],"increased":[123],"numbers":[124],"produced.":[129],"Preincubation":[130],"30":[137,197],"min":[138,191,198],"3":[140],"before":[142],"addition":[144,238],"camptothecin":[146],"etoposide":[148],"resulted":[149],"no":[151],"more":[152],"than":[155,209],"that":[156],"drugs":[163],"alone.":[164],"treatment":[166,194],"rapid":[172],"transient":[174,219],"increase":[175,223],"specific":[177],"activity":[178,227],"extractable":[180,202,225],"topoisomerases":[181],"II.":[184],"These":[185,247],"increases":[186],"maximum":[188],"at":[189],"2-5":[190],"activities":[200],"enzymes":[203],"equal":[205],"to":[206],"less":[208],"those":[210],"detected":[211],"extracts":[213],"from":[214],"untreated":[215],"controls.":[217],"The":[218],"nature":[220],"may":[228],"explain":[229],"kinetics":[231],"significance":[233],"order":[236],"maximal":[244],"activity.":[246],"data":[248],"are":[249],"consistent":[250],"also":[251],"topoisomerase-linked":[256],"lesions":[258],"TNF-mediated":[261],"potentiation":[262],"inhibitors.":[270]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2017,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}